Bioactivity:

Radotinib, and sometimes referred to by its investigational name IY5511, is a drug for the treatment of different types of Y, most notably Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) with resistance or intolerance of other tyrosi

CAS nr:

926037-48-1

Purity:

98%

Molecular Weight:

530,5

SMILES:

Cc1c(cc(cc1)C(=O)Nc1cc(cc(c1)n1cc(nc1)C)C(F)(F)F)Nc1nccc(n1)c1nccnc1

Formula:

C27H21F3N8O

Pathway:

Angiogenesis,Tyrosine Kinase/Adaptors,Cytoskeletal Signaling

Target:

Bcr-Abl,Bcr-Abl,Bcr-Abl